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Abstract
Much of the HSV-1 life cycle is carried out in the cell nucleus, including the expression, repli-
cation, repair, and packaging of viral genomes. Viral proteins, as well as cellular factors,
play essential roles in these processes. Isolation of proteins on nascent DNA (iPOND) was
developed to label and purify cellular replication forks. We adapted aspects of this method
to label viral genomes to both image, and purify replicating HSV-1 genomes for the identifi-
cation of associated proteins. Many viral and cellular factors were enriched on viral ge-
nomes, including factors that mediate DNA replication, repair, chromatin remodeling,
transcription, and RNA processing. As infection proceeded, packaging and structural com-
ponents were enriched to a greater extent. Among the more abundant proteins that copuri-
fied with genomes were the viral transcription factor ICP4 and the replication protein ICP8.
Furthermore, all seven viral replication proteins were enriched on viral genomes, along with
cellular PCNA and topoisomerases, while other cellular replication proteins were not de-
tected. The chromatin-remodeling complexes present on viral genomes included the
INO80, SWI/SNF, NURD, and FACT complexes, which may prevent chromatinization of the
genome. Consistent with this conclusion, histones were not readily recovered with purified
viral genomes, and imaging studies revealed an underrepresentation of histones on viral
genomes. RNA polymerase II, the mediator complex, TFIID, TFIIH, and several other tran-
scriptional activators and repressors were also affinity purified with viral DNA. The presence
of INO80, NURD, SWI/SNF, mediator, TFIID, and TFIIH components is consistent with pre-
vious studies in which these complexes copurified with ICP4. Therefore, ICP4 is likely in-
volved in the recruitment of these key cellular chromatin remodeling and transcription
factors to viral genomes. Taken together, iPOND is a valuable method for the study of viral
genome dynamics during infection and provides a comprehensive view of how HSV-1 se-
lectively utilizes cellular resources.
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Author Summary
HSV-1 is a human pathogen that infects over 50% of the population. The virus persists as
a latent infection in the ganglia of an infected host and upon stressful conditions is reacti-
vated to a lytic state in which it causes recurrent sores at the initial site of infection. During
lytic infection, HSV highjacks the host cell to propagate its genome and produce new virus
particles. However, there is limited knowledge of what cellular proteins interact with and
function on the viral genome. We therefore developed methods to purify viral genomes
from productively infected cells to identify associated viral and cellular proteins. We found
proteins and protein complexes that have previously been implicated in HSV infection to
be enriched on viral genomes, as well as several novel proteins that are likely involved in
productive infection. These data provide valuable insight into HSV biology. Furthermore,
these methods can be adapted to study other viruses, as well as other aspects of the HSV
life cycle.
Introduction
The genomes of eukaryotic DNA viruses vary in complexity with respect to the number of
genes they encode, and hence their dependence on host-cell functions. With the exception of
poxviruses, all replicate in the cell nucleus and therefore utilize the nuclear machinery for the
maintenance, replication, and expression of their genomes. The dynamic interactions between
viral and cellular proteins and the viral genome, function to mediate the different steps in the
life cycle of the virus, and hence determine the outcome of infection. These include interactions
that mediate the entry of the genome into the nucleus, its expression and replication, and ulti-
mately the packaging of nascent genomes in capsids.
Herpes simplex virus 1 (HSV-1) has a linear genome comprised of 152 kilobasepairs [1,2].
It enters the nucleus from the capsid through pores in the nuclear envelope [3–5]. The genome
then participates in a series of interactions that results in a nucleo-protein complex near ND10
structures [6]. Here, the genome is susceptible to activities of the intrinsic cellular antiviral re-
sponse. The genome also contains nicks and gaps, and these along with the genomic termini
elicit a DNA damage response, the nature of which may be consequential to viral infection [7].
Viral genomes initially associate with ND10 structures, where through the action of ICP0,
ND10 proteins are degraded or dispersed resulting in the prerequisite structure for efficient
transcription and replication [6,8]. Viral DNA replication then results in the formation large
replication compartments, which fill the host nucleus and concentrate viral and cellular factors
to replicating viral genomes [9].
HSV-1 encodes two transcription factors, VP16 [10,11] and ICP4 [12], which function
along with the cellular RNA polymerase II transcription machinery [13] to transcribe the viral
genome. These factors initially colocalize with prereplicative genomes [14–16] and these inter-
actions as well as those involving viral and cellular RNA-processing factors result in an ordered
cascade of viral gene expression [17,18]. Seven HSV gene products are sufficient in cells to rep-
licate DNA in an HSV-origin dependent manner [19]. While this set of viral proteins includes
a DNA-dependent DNA polymerase and other functional analogs of cellular DNA replication
proteins, it is not sufficient to drive origin-dependent replication in vitro, suggesting the re-
quirement for as yet unknown cellular proteins [20]. Finally, an additional set of proteins inter-
acts with the genome in the processes of cleaving unit length genomes and their packaging in
capsids [21]. These processes have been, and continue to be the focus of studies in many labo-
ratories since significant gaps exist in our understanding of all these processes, and how they
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ultimately contribute to viral multiplication and pathogenesis. A shortcoming contributing to
these gaps is our relative lack of knowledge of the proteins, particularly cell-derived, which in-
teract with viral genomes in different phases of infection.
Recently, ethynyl-modified nucleosides along with click chemistry and immunofluores-
cence were used to trace the fate of input adenovirus genomes in infected cells [22]. Nucleoside
analogs were also incorporated into replicating herpes simplex and vaccinia viral DNA to dem-
onstrate that this technique can be used to label other viral genomes and could potentially be
used to track these genomes throughout infection. In addition, ethynyl-modified nucleosides
have been used in a procedure known as isolation of proteins on nascent DNA (iPOND) to
identify the proteins at cellular replication forks [23–28]. This procedure involves the metabolic
incorporation of 5-ethynyl-2´-deoxyuridine (EdU) into the DNA, biotinylating the EdU-la-
beled DNA by click chemistry, followed by the affinity purification of the biotinylated DNA,
and the subsequent analysis of the proteins associated with it. We have adopted and modified
these procedures to enable the visualization of the HSV genome at different stages of infection,
as well as the interrogation of the viral and cellular proteins on replicated/replicating viral ge-
nomes. The results elucidate the viral and cellular proteins associating with viral DNA during
infection and provide a comprehensive view of the cellular machinery functioning on HSV
genomes.
Results
Labeling and imaging HSV genomes
Ethynyl-modified nucleosides have been used to prelabel and then track single incoming ade-
novirus genomes within infected cells [22]. While this approach was also used to examine HSV
genomes in replication compartments, input genomes were not imaged. We sought to deter-
mine if ethynyl-modified nucleosides could be used to label and track HSV genomes during
early (before DNA replication), as well as late (after DNA replication) stages of infection. We
also intended to use viral DNA imaging to optimize HSV genome labeling for purification of
viral genomes by iPOND.
Preliminary experiments demonstrated that EdU and EdC were poorly incorporated in
HSV DNA. We hypothesized that deletion of the HSV deoxyuridine triphosphatase (dUTPase)
and uracil glycosylase enzymes would increase incorporation into the viral genome. HSV-1
uracil glycosylase and dUTPase mutant strains were generated by introducing premature ter-
mination codons early in the reading frames of the UL2 and UL50 genes (Fig A in S1 Text). As
found for labeling of adenovirus genomes [22], ethynyl nucleoside incorporation into HSV ge-
nomes resulted in slightly reduced virus titers (Fig B in S1 Text). The same concentrations of
EdU or EdC had a greater effect on the titer of the UL2/UL50 double mutant virus than on
wild type KOS, suggesting that the double mutant is more efficiently labeled by both EdU and
EdC. EdU was used in all subsequent experiments.
To compare the relative amount of EdU incorporated into wild type and mutant genomes,
we carried out viral infection and DNA imaging as outlined in Fig 1A and 1B. EdU labeled
input genomes and replication compartments were tagged with Alexa Fluor 488 by click chem-
istry and visualized by fluorescence microscopy (Fig 2). Prelabeled UL2/UL50 mutant genomes
that colocalized with the viral transcription factor, ICP4, were visualized in the nucleus of in-
fected cells (Fig 2A). The distribution of ICP4 foci two hours after infection largely resembles
that observed previously after infection with HSV-1 at a MOI of 10 PFU/cell [29]. Using these
same conditions, we were unable to detect KOS genomes prelabeled with 2.5 μM EdU (Fig 2A).
We also visualized viral replication compartments that colocalize with ICP4 8 hpi in both wild
type KOS and UL2/UL50 mutant virus infected cells (Fig 2B). While it was possible to detect
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EdU labeling coinciding with ICP4 staining in KOS infected cells, significantly more was ob-
served with the UL2/UL50 mutant. Taken together, the UL2/UL50 mutant virus incorporates
more EdU into its genome during DNA replication and allows for more sensitive imaging of
HSV-1 viral DNA during infection.
Optimization and validation of HSV iPOND
To identify the viral and cellular proteins that function on viral DNA at different stages of in-
fection, we adapted the iPONDmethod [25] for analysis of viral genomes and associated
Fig 1. Schematic representation of procedures used in this paper. (A) Resting MRC-5 cells in G0 were infected with either prelabeled (left) or unlabeled
(right) virus. To assay unreplicated viral DNA (left), prelabeled genomes were processed less than four hpi. To assay viral replication compartments (right),
EdU (orange stars) was added to the growth medium during viral DNA replication ( 4 hpi) and genomes were assayed 2–4 hours after the addition of EdU.
EdU labeled DNA is orange. (B) Viral and cellular DNA, as well as viral and cellular proteins were labeled and visualized as described in the experimental
procedures. DNA imaging experiments were carried out in proliferating Vero cells. Viral DNA is green. (C) and (D) iPOND and aniPOND experiments were
carried out as described. aniPOND (accelerated native iPOND) is a modified version of iPOND that does not involve crosslinking and therefore requires less
stringent wash conditions during purification.
doi:10.1371/journal.ppat.1004939.g001
Fig 2. Visualization of EdU labeled HSV-1 genomes. (A) Prelabeled input viral genomes were visualized in the nucleus of infected cells 2 hpi. Vero cells
were infected with wild type KOS or the UL2/UL50 mutant virus carrying unlabeled (0 μM) or prelabeled viral genomes. Labeled virus stocks were generated
by growing KOS or UL2/UL50 mutant in the presence of 1.25 or 2.5 μMEdU as described in the experimental procedures. Cellular DNA was visualized by
Hoechst staining, viral DNA by click chemistry with EdU, and ICP4 by immunofluorescence. Merged panels show colocalization of viral DNA with ICP4.
Prelabeled KOS DNA could not be detected under these conditions. (B) Cells infected with KOS or UL2/UL50 mutant were grown in the presence of 0 or
2.5 μMEdU for 4–8 hpi. Uninfected cells were grown in the presence of EdU for 4 hours. DNA imaging was as described in (A).
doi:10.1371/journal.ppat.1004939.g002
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proteins. To optimize viral iPOND, we initially considered several factors. Proliferating cells
grown in the presence of EdU incorporate EdU into their genomes during DNA replication
(Fig 2B, uninfected, 2.5 μM). Therefore, conditions in which viral DNA, but not cellular DNA
is labeled in the presence of EdU were established. Addition of EdU to the growth medium of
proliferating Vero cells that were mock- or HSV-1-infected resulted in labeling of 65% or 29%
of cellular genomes (Fig C in S1 Text, panels Vero cells), respectively. HSV infection inhibits
G1/S and G2/M phases of the cell cycle [30,31] consistent with less labeling of cellular DNA in
infected cells. In contrast to proliferating cells, less than 1% of cellular genomes were labeled
with EdU when human MRC-5 fibroblast cells that were grown to confluency were infected
with HSV in the presence of EdU (Fig C in S1 Text, panels MRC-5 cells). Therefore, resting
MRC-5 cells were used in iPOND experiments to avoid contamination with cellular DNA.
These cells also have the added advantage that they are a natural host to lytic HSV infection
and they do not express high levels of cellular glycosylases to limit cleavage of labeled viral ge-
nomes [32].
One of the limitations of iPOND is that a large amount of EdU-labeled DNA is required to
pull down enough protein for proteomic analysis [25]. Because the UL2/UL50 mutant virus is
more efficiently labeled with EdU than wild type virus, we hypothesized that more viral DNA
and associated proteins could be purified by iPOND of the mutant virus. We tested iPOND for
the purification of proteins associated with genomes of wild type KOS, UL2 and UL50 single
mutant, and UL2/UL50 double mutant viruses (outlined in Fig 1C). The relative protein yield
for each virus was compared by western blot for the viral transcription factor ICP4 (Fig D in S1
Text). ICP4 associates with viral genomes throughout infection and is a good indicator of pro-
tein yield. The negative control was iPOND carried out on virus-infected cells incubated in the
absence of EdU. For all viruses tested, ICP4 was not detected in the negative control, but was
detected when iPOND was carried out on viral genomes that were labeled with EdU. The great-
est relative amount of ICP4 was detected with the UL2/UL50 mutant virus, consistent with
fluorescence imaging of labeled viral genomes (Fig 2B). Therefore, the UL2/UL50 mutant virus
was used for iPOND experiments.
To identify the proteins associated with viral genomes by iPOND, we labeled viral DNA at
three time points during DNA replication. EdU was added to the medium of infected cells at
4–6, 6–8, or 8–12 hpi and cells were fixed for iPOND at 6, 8, or 12 hpi, respectively. Proteins re-
covered by iPOND were probed for ICP4 by western blotting (Fig 3A). ICP4 was detected at all
time points, but not in the unlabeled negative control. To ensure that DNA isolated by iPOND
was viral, input DNA from cell lysates and DNA bound to streptavidin-coated beads was ex-
tracted, the amount of viral DNA was measured, and the percentage of viral/total DNA was
calculated (Fig 3B). DNA eluted from beads during iPOND experiments was nearly 100% viral
in nature. This is a significant enrichment compared to input DNA (0.2–1.5% viral). To deter-
mine if the entire viral genome was labeled and purified in our assays, high throughput DNA
sequencing was carried out on DNA eluted from streptavidin-coated beads (Fig E in S1 Text).
At all time points, the distribution of bead-bound DNA was relatively homogeneous across the
viral genome. Taken together, iPOND should enable the specific purification of proteins asso-
ciated with the entire replicated HSV-1 genome.
Factors that mediate host cell nuclear processes are enriched on HSV-1
genomes during viral DNA replication
To determine the identity of proteins bound to viral genomes at 6, 8, and 12 hpi, mass spec-
trometry was carried out on proteins that were crosslinked to viral DNA and purified by
iPOND. Two independent iPOND experiments were carried out for each time point, each with
Selective Recruitment to HSV Genomes
PLOS Pathogens | DOI:10.1371/journal.ppat.1004939 May 27, 2015 6 / 35
an unlabeled virus negative control that was prepared on the same day with the same cells,
virus, and reagents. Proteins were considered significantly enriched on viral genomes if they
were identified with high confidence in duplicate experiments to be enriched by at least four
fold over the negative control. The types of proteins identified at all three time points are sum-
marized in Fig 3C and individual complexes and proteins are listed in Tables 1–6 and Table A
in S1 Text. The most abundant types of proteins enriched on isolated viral DNA include those
involved in RNA processing, transcription, chromatin remodeling, DNA repair, and DNA
replication.
Fig 3. iPOND detects viral and cellular proteins associated with replicated HSV-1 genomes. (A) ICP4 was detected by western blot of protein eluates
from iPOND carried out on viral genomes grown in the presence of EdU at 4–6, 6–8, and 8–12 hpi. The control was iPOND carried out on virus grown in the
absence of EdU (−) and harvested 8 hpi. Purified ICP4 is shown. (B) DNA eluted from streptavidin-coated beads during iPOND experiments in (A) is viral.
The amount of viral DNA present in cell lysates (input) and eluted from beads (bound) during iPOND experiments was measured by qRT-PCR of the viral
thymidine kinase (TK) gene. The ratio of viral DNA (vDNA) to total DNA was calculated and is presented as log %vDNA. (C) Pie charts summarize proteins
that were identified by mass spectrometry of protein eluates from iPOND carried out 6, 8, and 12 hpi with UL2/UL50 mutant virus. Values indicate the number
of proteins identified for each functional category. (D) Venn diagrams depict the overlap of proteins identified by iPOND at each time point.
doi:10.1371/journal.ppat.1004939.g003
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Furthermore, proteins that mediate nuclear transport, components of the nuclear cytoskele-
ton, and HSV structural proteins were bound to viral genomes. Several trends are present in
these data. First, the total number of proteins that were recovered increased with time of infec-
tion. This is consistent with increasing amounts of labeled DNA as replication proceeds, allow-
ing for more sensitive detection of bound proteins. Second, there was a relative increase in
proteins that function in post-transcriptional RNA processing, as well as viral structural pro-
teins with time. The increase in viral structural proteins including tegument proteins, capsid
assembly factors, portal protein (UL6), and capsid proteins reflects the packaging of nascent
genomes at later times during infection (Table 1).
Comparison of proteins identified at each time point suggests that the individual proteins
found on replicated/replicating viral genomes at 6, 8, and 12 hpi were relatively similar (Fig 3D).
Table 1. HSV-1 proteins identified by iPOND and aniPOND.
HSV Proteins iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
Tegument
UL14 TEG3 P04291 0 0 4 4 0 2 5 2 4 15 3 0 7 4
UL21 TEG4 P10205 14 0 5 22 2 0 5 41 3 22 18 0 7 6
UL46 TEG1 P10230 10 6 6 30 6 7 8 39 0 86 28 3 101 115
UL47 TEG5 P10231 35 5 78 317 44 16 117 340 49 188 120 16 173 209
VP16 Transcription factor P06492 4 11 16 85 21 6 52 108 9 86 81 13 127 158
ICP0 E3 ubiquitin-protein ligase P08393 0 0 0 6 0 0 3 22 0 9 15 0 7 69
Capsid
UL38 Triplex capsid protein VP19c P32888 25 33 36 109 8 20 78 178 7 4 8 0 12 34
UL35 Capsid protein VP26 P10219 0 0 0 4 0 7 3 0 5 10
UL19 Major capsid protein VP5 P06491 151 302 284 588 137 239 376 615 66 93 129 18 219 262
UL6 Portal protein P10190 5 11 21 28 0 7 9 21 0 93 4 4 180 94
Capsid Assembly
UL37 Capsid assembly protein P10221 0 0 0 2 0 0 0 11 0 0 21 0 0 30
UL26 Capsid scaffolding protein
VP22a
P10210 0 6 7 40 0 6 16 34 0 0 5 3 6 15
Packaging proteins
UL17 P10201 0 0 9 18 0 9 22 44 0 9 12 0 16 25
UL32 P10216 0 0 0 13 0 0 2 19 0 0 4 0 12 22
UL25 P10209 0 0 13 42 4 0 17 55 0 0 3 0 2 0
Other viral proteins
UL2 Uracil glycosylase P10210 0 0 16 0 0 47
UL3 Nuclear phosphoprotein P10221 0 0 14 21 2 0 9 46 3 68 12 2 26 26
UL50 Deoxyuridine 5'-triphosphate
nucleotidohydrolase
P10234 0 2 2 2 2 18 15 19 0 7 78 2 2 116
UL13 Serine/threonine-protein
kinase
P04290 0 8 0 0 11 4
UL31 Virion egress protein P10215 2 0 12 32 0 0 6 35 0 4 7 0 5 24
Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values
indicate spectral counts determined by mass spectrometry. Identified viral replication, transcription, and RNA processing factors are listed in Tables 2, 3,
and 6, respectively.
doi:10.1371/journal.ppat.1004939.t001
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Table 3. Transcription factors identified by iPOND and aniPOND.
Transcription Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
DNA-directed RNA polyermase II Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
POLR2A DNA-directed RNA polymerase II
subunit RPB1
P24928 0 33 36 7 0 95 49 48 0 54 10 0 111 74
POLR2B DNA-directed RNA polymerase II
subunit RPB2
P30876 0 20 40 4 0 97 61 51 0 31 3 0 87 50
POLR2C DNA-directed RNA polymerase II
subunit RPB3
P19387 0 0 2 0 0 5 0 2 0 2 2 0 6 10
POLR2D DNA-directed RNA polymerase II
subunit RPB4
O15514 0 0 2 0 0 2 0 0 2 0
POLR2E DNA-directed RNA polymerases II
subunit RPB5
P19388 0 3 7 2 0 3 0 2 0 4 3 0 6 7
POLR2F DNA-directed RNA polymerases II
subunit RPB6
P61218 0 2 0
POLR2G DNA-directed RNA polymerase II
subunit RPB7
P62487 0 2 0 0 0 5 0 0 7 5
POLR2H DNA-directed RNA polymerases II
subunit RPB8
P52434 0 2 2
POLR2I DNA-directed RNA polymerase II
subunit RPB9
P36954 0 7 2
POLR2J DNA-directed RNA polymerase II
subunit RPB11-a
P52435 0 2 2 0
POLR2L DNA-directed RNA polymerases II
subunit RPB10
P62875 0 2 0 0
Mediator of RNA polymerase II transcription
MED1 Mediator of RNA polymerase II
transcription subunit 1
Q15648 0 6 8 0 52 32
MED4 Mediator of RNA polymerase II
transcription subunit 4
Q9NPJ6 0 2 0 0 7 6
MED6 Mediator of RNA polymerase II
transcription subunit 6
O75586 0 4 0 0 12 7
MED7 Mediator of RNA polymerase II
transcription subunit 7
O43513 0 7 0
MED8 Mediator of RNA polymerase II
transcription subunit 8
Q96G25 0 7 5
MED10 Mediator of RNA polymerase II
transcription subunit 10
Q9BTT4 0 4 0
MED11 Mediator of RNA polymerase II
transcription subunit 11
Q9P086 0 3 2
MED12 Mediator of RNA polymerase II
transcription subunit 12
Q93074 0 14 0 0 82 46
MED13 Mediator of RNA polymerase II
transcription subunit 13
Q9UHV7 0 6 0
MED13L Mediator of RNA polymerase II
transcription subunit 13-like
Q71F56 0 11 0
MED14 Mediator of RNA polymerase II
transcription subunit 14
O60244 0 22 10 0 156 119
MED15 Mediator of RNA polymerase II
transcription subunit 15
Q96RN5 0 15 3
MED16 Mediator of RNA polymerase II
transcription subunit 16
Q9Y2X0 0 18 9 0 51 31
MED17 Mediator of RNA polymerase II
transcription subunit 17
Q9NVC6 0 9 5 0 37 27
MED18 Mediator of RNA polymerase II
transcription subunit 18
Q9BUE0 0 3 3 0 12 6
MED20 Mediator of RNA polymerase II
transcription subunit 20
Q9H944 0 6 4 0 11 11
(Continued)
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Table 3. (Continued)
Transcription Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
DNA-directed RNA polyermase II Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
MED21 Mediator of RNA polymerase II
transcription subunit 21
Q13503 0 2 0 0 4 2
MED22 Mediator of RNA polymerase II
transcription subunit 22
Q15528 0 4 3
MED23 Mediator of RNA polymerase II
transcription subunit 23
Q9ULK4 0 59 27 0 132 110
MED24 Mediator of RNA polymerase II
transcription subunit 24
O75448 0 35 12 0 83 65
MED25 Mediator of RNA polymerase II
transcription subunit 25
Q71SY5 0 16 16
MED27 Mediator of RNA polymerase II
transcription subunit 27
Q6P2C8 0 4 2 0 16 17
MED28 Mediator of RNA polymerase II
transcription subunit 28
Q9H204 0 2 2 0 3 4
MED29 Mediator of RNA polymerase II
transcription subunit 29
Q9NX70 0 3 2 0 8 10
MED30 Mediator of RNA polymerase II
transcription subunit 30
Q96HR3 0 4 0 0 7 4
MED31 Mediator of RNA polymerase II
transcription subunit 31
Q9Y3C7 0 7 6 0 13 8
CCNC Cyclin-C P24863 0 2 3 0 6 5
CDK8 Cyclin-dependent kinase 8 P49336 0 8 10
Transcription initiation factor TFIID
TAF1 Transcription initiation factor TFIID
subunit 1
P21675 0 5 12
TAF2 Transcription initiation factor TFIID
subunit 2
Q6P1X5 0 9 0 0 18 25
TAF3 Transcription initiation factor TFIID
subunit 3
Q5VWG9 0 0 3
TAF4 Transcription initiation factor TFIID
subunit 4
O00268 0 5 0
TAF5 Transcription initiation factor TFIID
subunit 5
Q15542 0 8 2 0 62 45
TAF6 Transcription initiation factor TFIID
subunit 6
P49848 0 20 6 0 48 41
TAF9 Transcription initiation factor TFIID
subunit 9
Q16594 0 8 10
TAF9B Transcription initiation factor TFIID
subunit 9B
Q9HBM6 0 8 3 0 6 0
TAF10 Transcription initiation factor TFIID
subunit 10
Q12962 0 2 0 0 2 2
TAF12 Transcription initiation factor TFIID
subunit 12
Q16514 0 4 0 0 2 3
TAF15 TATA-binding protein-associated factor
2N
Q92804
TBP TATA-box binding protein P20226 0 12 17
Transcription initiation factor TFIIH
XPB TFIIH basal transcription factor
complex helicase ERCC3
P19447 0 0 9 0 39 60
XPD TFIIH basal transcription factor
complex helicase ERCC2
P18074 0 0 4 0 36 45
CDK7 Cyclin-dependent kinase 7 P50613 0 15 19
MAT1 CDK-activating kinase assembly factor
MAT1
P51948 0 8 9
(Continued)
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There are significant overlaps between the three different time points with most proteins identi-
fied at two or more of the times sampled. The biggest difference was seen at 12 hpi and this re-
flects the increase in structural proteins, as well as the larger number of proteins recovered by
iPOND at this time point.
Comparative analysis of replication proteins found on replicated cellular and viral DNA re-
veals the specificity of isolation of proteins on viral DNA (Table 2). Cellular replication forks
are enriched for cellular replication factors including components of cellular DNA polymerase,
clamp loader complex, MCM complex, as well as other replisome-associated proteins such as
topoisomerases and PCNA [23,26,28]. In contrast, in our studies viral DNA was enriched for
all seven components of the viral replication machinery including: ICP8, UL30 (polymerase),
UL5/UL8/UL52 (helicase/primase complex), UL9 (origin binding protein), and UL42 (proces-
sivity factor). The cellular counterparts to these viral proteins were not enriched on viral
Table 3. (Continued)
Transcription Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
DNA-directed RNA polyermase II Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
CCNH Cyclin-H P51946 0 0 2 0 8 9
GTF2H1 General transcription factor 2H subunit
1
P32780 0 6 14
GTF2H2 General transcription factor 2H subunit
2
Q6P1K8 0 2 6 0 21 38
GTF2H3 General transcription factor 2H subunit
3
Q13889 0 0 3 0 13 13
GTF2H4 General transcription factor 2H subunit
4
Q92759 0 0 5 0 17 36
Viral transcription regulators
VP16 Tegument protein VP16 P06492 4 11 16 85 21 6 52 108 9 86 81 13 127 158
ICP4 Major viral transcription factor P08392 46 300 199 247 31 259 266 366 133 613 585 113 1146 1255
ICP22 Transcriptional regulator ICP22 P04485 8 60 18 46 6 51 69 74 0 26 17 0 29 44
Other cellular transcription factors
TRIM28 Transcription intermediary factor 1-beta Q13263 0 130 94 117 3 81 121 162 0 26 19 0 121 181
CTCF Transcriptional repressor CTCF P49711 0 2 6 24 0 26 12 0 41 54
TFII-I General transcription factor II-I P78347 0 69 61 73 0 35 49 73 0 3 0 0 21 10
SPT5 Transcription elongation factor
SUPT5H (DSIF component)
O00267 0 25 7 6 0 33 20 27 0 15 2 0 37 21
SPT6 Transcription elongation factor
SUPT6H
Q7KZ85 0 5 6 0 0 28 10 14 0 17 0 0 38 14
CSK21 Casein kinase II subunit alpha P68400 0 7 3 0 9 12
CSK2B Casein kinase II subunit beta P67870 0 6 2 2 10 7
FUBP1 Far upstream element-binding protein
1
Q96AE4 2 25 32 47 7 32 31 39
FUBP2 Far upstream element-binding protein
2
Q92945 9 41 22 46 6 27 32 38
MATR3 Matrin-3 P43243 0 52 41 69 0 41 50 105 0 2 0 0 16 5
BCLF1 Bcl-2-associated transcription factor 1 Q9NYF8 0 0 14 15 0 12 13 29 10 23 14 16 54 47
CDC5L Cell division cycle 5-like protein Q99459 0 0 11 10 0 4 11 17 0 2 0 0 8 5
NONO Non-POU domain-containing octamer-
binding protein
Q15233 18 85 90 123 22 85 121 133 31 67 60 8 88 75
CN166 UPF0568 protein C14orf166 Q9Y224 0 9 5 10 0 2 3 14 0 2 6 0 7 16
Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values
indicate spectral counts determined by mass spectrometry.
doi:10.1371/journal.ppat.1004939.t003
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Table 4. Chromatin remodeling factors and histones identified by iPOND and aniPOND.
Chromatin Remodeling Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
FACT complex Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
SUPT16h FACT complex subunit SPT16 Q9Y5B9 0 74 61 47 0 77 51 47 0 15 14 0 8 38
SSRP1 FACT complex subunit SSRP1 Q08945 0 47 42 37 0 35 29 49 0 5 18 0 9 41
INO80 complex
INO80 DNA helicase (KIAA1259) Q9ULG1 0 6 0 0 26 27
ARP5 Actin-related protein 5 Q9H9F9 0 3 0 0 3 3
ARP8 Actin-related protein 8 Q9H981 0 9 13
RUVBL1 RUVB-like 1 (TIP49A) Q9Y265 8 46 40 47 0 13 21 24 0 93 39 0 104 112
RUVBL2 RUVB-like 2 (TIP49B) Q9Y230 2 12 17 15 0 9 6 24 0 57 34 0 65 79
NURD complex
CHD3 Chromodomain-helicase-DNA-
binding protein 3
Q12873 0 0 0 9 0 0 9 0 23 41
CHD4 Chromodomain-helicase-DNA-
binding protein 4
Q14839 0 28 22 42 0 36 35 61 0 57 77 0 81 124
HDAC1 Histone deacetylase 1 Q13547 0 32 15 0 25 24
HDAC2 Histone deacetylase 2 Q92769 0 0 0 6 0 12 8 22 0 9 0 0 79 79
RBBP4 Histone-binding protein RBBP4
(RbAp48)
Q09028 0 31 13 17 0 35 22 40 0 40 17 0 50 62
MTA1 Metastasis-associated protein
MTA1
Q13330 0 0 0 11 0 3 5 3 0 21 10 0 45 28
MTA2 Metastasis-associated protein
MTA2
O94776 0 11 19 23 0 5 11 19 0 27 22 0 61 67
SWI/SNF complex
ARID1A BAF250A (Swi1) O14497 0 0 0 6 0 3 5 3 0 4 10 0 9 21
SMARCA4 BRG1 (Swi2/Snf2) P51532 0 13 10 0 0 11 22 22 0 29 20 0 51 91
SMARCC1 BAF155 (Swi3) Q92922 0 0 0 3 0 0 7 8 0 17 0 0 22 21
SMARCC2 BAF170 (Swi3) Q8TAQ2 0 16 12 24 0 13 22 26 0 31 25 0 61 100
SMARCD2 Swp73 Q92925 0 3 3 0 3 12
ACTL6A BAF53 (Swp61) O96019 0 8 6 6 0 0 0 2 0 7 8 0 26 38
SMARCB1 BAF47 (Snf5) Q12824 0 7 4 0 3 12
SMARCE1 BAF57 Q969G3 0 0 0 2 0 0 0 2 0 2 0 0 8 4
COMPASS lysine methyltransferase complex
RBBP5 Retinoblastoma binding protein 5 Q15291 0 9 5 0 31 27
WDR82 WD repeat-containing protein 82 Q6UXN9 0 0 4 7 0 4 0 7 0 12 10
WDR5 WD repeat-containing protein 5 P61964 0 0 2 2 0 4 7 0 20 25
ASH2L Q9UBL3 0 2 0 0 3 6
HCFC1 Host cell factor 1 P51610 0 0 4 0 0 0 0 6 0 6 11
MLL1 Histone-lysine N-methyltransferase
2A (Set1)
Q03164 0 6 0 0 2 2
Chromatin/DNA modifying enzymes
DNMT1 DNA methyltransferase 1 P26358 0 6 3 2 0 11 14 4 0 0 4 0 0 7
PRMT1 Protein arginine methyltransferase 1
(ANM1)
Q9Y3Y2 2 20 15 30 2 21 15 29
NAT10 N-acetyltransferase 10 Q9H0A0 0 0 4 10 0 4 8 12 0 5 5 0 11 3
MBB1A Myb-binding protein 1A (HDAC
activity)
Q9BQG0 0 0 4 7 0 7 15 22 0 73 21 0 13 10
KDM1A Lysine-specific histone demethylase
1A (LSD1A)
O60341 0 3 0 4 0 0 2 0 0 21 13 0 62 64
APOBEC3C DNA dC—> dU editing enzyme Q9NRW3 0 11 7 0 6 8
Chromatin associated and remodeling factors
HMGB1 High mobility group box 1 P09429 3 57 45 98 29 107 116 148 2 9 11
HMGB2 High mobility group box 2 P26583 0 12 0 6 0 28 26 46 0 3 6
(Continued)
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genomes. One exception to this is the cellular processivity factor, PCNA. This protein was en-
riched on viral genomes at all times tested with the highest levels at 6 hpi, decreasing with time.
Furthermore, cellular topoisomerases TOP1, TOP2a, and TOP2b were abundant on viral ge-
nomes and likely play a role in virus replication or other process.
aniPOND is an alternative method to purify viral genomes and
associated proteins
Accelerated native iPOND (aniPOND) is a modified version of iPOND that is quicker and
does not utilize crosslinking [33]. It involves native conditions during purification, while
iPOND involves crosslinking and stringent wash conditions (Fig 1C and 1D). We therefore
predicted that aniPOND would reveal a unique set of proteins involved in viral genome me-
chanics compared to iPOND because less direct interactors could be detected.
To obtain a more comprehensive view of proteins bound to viral genomes, we carried out
aniPOND on KOS and UL2/UL50 mutant viruses that were incubated in the presence of EdU
from 4–8 hpi and harvested at 8 hpi. Proteins eluted from viral DNA during aniPOND were as-
sayed for ICP4 by western blotting (Fig 4A). ICP4 was detected when the infection was carried
out in the presence of EdU (lanes 3 and 4), but not in the absence of EdU (lane 1). Importantly,
using aniPOND it was also possible to recover ICP4 associated with wild type genomes, howev-
er, greater amounts where recovered in the sample with the mutant virus extract. In this experi-
ment, significantly less (~2%) sample was required to isolate a similar amount of ICP4 to that
recovered with iPOND. Therefore aniPOND is more efficient for the recovery of labeled viral
DNA and associated proteins than iPOND. This is in agreement with comparison of the purifi-
cation of replisome-associated proteins by each method [33].
To verify the specificity of aniPOND for the purification of replicated viral genomes, we car-
ried out aniPOND on cells infected with the UL2/UL50 mutant virus that was maintained in
the presence of acycloguanosine (ACG, acyclovir), a potent inhibitor of viral DNA replication.
In the absence of viral DNA replication, DNA was not recovered by aniPOND and ICP4 was
not detected by western blotting (Fig 4A, lane 2). To further validate aniPOND for purification
of viral genomes, we determined the relative amount of viral DNA/total DNA purified by this
method. DNA eluted from beads during aniPOND experiments was almost 100% viral in na-
ture (Fig 4B, bound DNA, +EdU-ACG). This is a significant enrichment compared to the
Table 4. (Continued)
Chromatin Remodeling Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
FACT complex Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
CBX3 Chromobox homolog 3 Q13185 0 6 3 4 0 8 12 17 0 7 0 0 5 5
SMARCA5 hSNF2H O60264 0 35 27 27 0 25 24 37 0 51 37 0 54 84
SMHD1 SMC hinge domain-containing
protein 1
A6NHR9 0 41 42 23 0 43 31 42 0 28 37 0 106 111
DEK P35659 0 2 2 13 3 20 14 21 0 11 13 0 57 42
Histones
H1.2 Histone H1.2 |P16403 23 66 65 47 154 181 180 184 0 53 29 36 146 140
H1.4 Histone H1.4 P10412 115 142 142 156 0 26 30 11 153 135
Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values
indicate spectral counts determined by mass spectrometry.
doi:10.1371/journal.ppat.1004939.t004
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percent viral DNA present in lysates for this condition (input DNA,<2%). Very little DNA
was detected when aniPOND was carried out on virus grown in the absence of EdU (bound
DNA,-EdU) or in the presence of ACG (+ACG), consistent with specific purification of repli-
cated viral DNA by aniPOND.
To determine the identity of proteins that copurified with viral genomes, mass spectrometry
was carried out on samples prepared by aniPOND of labeled UL2/UL50 mutant and wild type
KOS genomes at 8 hpi. Two independent experiments were carried out for each virus, with an
unlabeled virus negative control that was done on the same day with the same cells and re-
agents. Almost twice as many proteins were identified with high confidence by aniPOND
Table 5. Cellular repair proteins identified by iPOND and aniPOND.
Repair Proteins iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
DSB recognition Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
KU80 XRCC5 P13010 6 106 79 104 2 88 96 120 0 32 23 0 38 51
KU70 XRCC6 P12956 0 79 64 103 0 42 52 85 0 8 10 0 24 46
MRN complex—DSB repair
RAD50 Repair protein Rad50 Q92878 0 49 51 41 0 84 83 66 0 6 6 0 144 84
MRE11 Meiotic recombination 11 homolog P49959 0 8 6 11 0 25 11 32 0 15 8
NBS1 Nibrin O60934 0 2 0 0 0 2 2
Mismatch repair
MSH2 MutS homolog 2 P43246 0 35 37 18 0 28 17 25 0 69 28 0 105 63
MSH3 MutS homolog 3 P20585 0 7 16 0 67 51
MSH6 MutS homolog 6 P52701 0 22 17 11 0 27 19 27 0 48 0 0 64 0
MLH1 MutL homolog 1 P40692 0 0 4 0 0 2 0 0
Base excision repair
PARP1 Poly [ADP-ribose] polymerase 1 P09874 0 40 50 70 0 35 42 60 6 108 108 0 296 265
XRCC1 X-ray repair cross-complementing
protein 1
P18887 0 0 8 0 0 0 6 4 0 2 19 0 33 43
LIG3 DNA ligase 3 P49916 0 4 2 2 0 3 0 0 0 19 43 0 157 145
UL2 Viral uracil DNA glycosylase Q1KMD3 0 0 16 0 0 47
APEX DNA-(apurinic or apyrimidinic site)
lyase
P27695 0 9 9 10 0 15 13 19 0 0 2 0 0 8
Cohesin complex
SMC3 Structural maintenance of
chromosomes protein 3
Q9UQE7 0 73 92 105 0 57 82 111 0 150 113 0 149 238
SMC1A Structural maintenance of
chromosomes protein 1A
Q14683 0 71 63 72 0 40 58 91 0 142 56 0 131 223
STAG1 SCC3A Q8WVM7 0 0 0 2 0 0 9 10 0 63 42 0 44 67
STAG2 SCC3B Q8N3U4 0 0 6 4 0 30 20 0 33 47
RAD21 SCC1 O60216 0 0 6 9 0 9 0 0 17 42
PDS5B Cohesin complex interacting protein Q9NTI5 0 3 0 12 0 22 27 55 0 42 50 0 107 158
Other repair proteins
RECQL ATP-dependent DNA helicase Q1 P46063 0 29 26 52 0 28 26 55 2 32 115 2 184 304
ATM Ataxia telangiectasia mutated Q13315 0 14 8 6 0 28 12 11 0 3 0 0 111 67
TRRAP Transformation/transcription domain-
associated protein
Q9Y4A5 0 0 0 2 0 34 18 0 141 113
DNA-PKcs DNA-dependent protein kinase
catalytic subunit
P78527 0 11 2 17 0 27 44 46 0 8 45 0 119 138
Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values
indicate spectral counts determined by mass spectrometry.
doi:10.1371/journal.ppat.1004939.t005
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Table 6. RNA processing factors identified by iPOND and aniPOND.
RNA Processing Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
TREX complex Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
THOC1 THO complex subunit 1 Q96FV9 0 6 6 0 14 25
THOC2 THO complex subunit 2 Q8NI27 0 18 3 19 0 0 5 12 0 39 18 0 88 66
THOC3 THO complex subunit 3 Q96J01 0 3 0 0 7 12
THOC4 THO complex subunit 4 Q86V81 0 0 0 2 13 21 20 23 16 8 10 51 65 80
THOC5 THO complex subunit 5 Q13769 0 2 0 0 21 17
THOC6 THO complex subunit 6 Q86W42 0 6 4 0 17 21
THOC7 THO complex subunit 7 Q6I9Y2 0 6 0 0 6 5
Heterogeneous nuclear ribonucleoproteins
hnRNP AB Heterogeneous nuclear
ribonucleoprotein A/B
Q99729 0 43 23 46 8 31 20 41 5 28 4 0 22 25
hnRNP A0 Heterogeneous nuclear
ribonucleoprotein A0
Q13151 0 0 7 14 7 15 11 30 5 13 0 0 16 21
hnRNP A1 Heterogeneous nuclear
ribonucleoprotein A1
P09651 34 110 82 127 87 170 155 243 73 177 107 35 137 135
hnRNP A2/
B1
Heterogeneous nuclear
ribonucleoproteins A2/B1
P22626 30 88 69 124 93 183 174 248 74 235 100 33 180 199
hnRNP A3 Heterogeneous nuclear
ribonucleoprotein A3
P51991 0 35 11 51 42 101 70 144 10 138 37 27 117 100
hnRNP C Heterogeneous nuclear
ribonucleoproteins C1/C2
P07910 40 134 123 176 38 116 114 176 53 174 71 55 135 127
hnRNP DL Heterogeneous nuclear
ribonucleoprotein D-like
O14979 0 8 4 24 7 15 30 37 0 5 4 4 11 10
hnRNP D Heterogeneous nuclear
ribonucleoprotein D0
Q14103 11 59 37 68 29 90 59 128 2 41 15 3 65 57
hnRNP F Heterogeneous nuclear
ribonucleoprotein F
P52597 2 5 23 6 4 41 41 63
hnRNP H Heterogeneous nuclear
ribonucleoprotein H
P31943 29 91 74 106 52 140 116 173 27 92 55 0 98 79
hnRNP H2 Heterogeneous nuclear
ribonucleoprotein H2
P55795 0 0 11 42 0 17 0 59 0 7 0
hnRNP H3 Heterogeneous nuclear
ribonucleoprotein H3
P31942 0 0 17 16 7 34 18 28 10 34 10 3 22 16
hnRNP L Heterogeneous nuclear
ribonucleoprotein L
P14866 16 61 57 79 50 73 93 112 38 127 58 14 123 98
hnRNP M Heterogeneous nuclear
ribonucleoprotein M
P52272 32 162 121 155 25 128 137 165 20 150 34 2 80 55
hnRNP U Heterogeneous nuclear
ribonucleoprotein U
Q00839 48 161 114 195 105 183 235 267 28 105 71 16 127 121
hnRNP
UL1
Heterogeneous nuclear
ribonucleoprotein U-like protein 1
Q9BUJ2 0 17 8 19 0 19 16 17
hnRNP
UL2
Heterogeneous nuclear
ribonucleoprotein U-like protein 2
Q1KMD3 2 21 18 29 4 31 29 53 4 36 10 5 63 60
RNA helicases
DDX3X ATP-dependent RNA helicase
DDX3X
O00571 9 12 2 15 0 2 0 0 3 28 21 2 19 26
DDX5 Probable ATP-dependent RNA
helicase DDX5
P17844 15 80 70 105 6 65 61 78 24 78 72 6 65 59
DDX17 Probable ATP-dependent RNA
helicase DDX17
Q92841 9 80 74 92 27 87 94 98 0 18 11 0 24 22
DDX23 Probable ATP-dependent RNA
helicase DDX23
Q9BUQ8 0 2 13 14 0 4 6 8 0 24 6 0 42 36
DDX42 ATP-dependent RNA helicase
DDX42
Q86XP3 0 0 8 5 0 12 10 15
(Continued)
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Table 6. (Continued)
RNA Processing Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
TREX complex Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
DDX46 Probable ATP-dependent RNA
helicase DDX46
Q7L014 0 4 7 16 0 0 10 14 0 20 13
DHX15 Putative splicing factor ATP-
dependent RNA helicase
O43143 0 30 30 44 0 38 6 0 32 12
DHX9 ATP-dependent RNA helicase A Q08211 31 106 103 143 31 96 103 123 44 153 87 7 99 87
Splicing factors
ELAV1 ELAV-like protein 1 Q15717 0 9 11 16 6 17 19 20 7 49 8 5 38 17
KIAA1967 DBIRD complex subunit Q8N163 0 0 10 4 0 2 6 11 0 0 2
LA Lupus LA protein P05455 0 3 6 8 0 6 3 21
LEG1 Galectin 1 P09382 6 23 17 31 9 40 27 45 7 10 11 14 24 28
MAGOHB Protein mago nashi homolog 2 Q96A72 0 0 0 2 0 6 5 6 3 15 4 0 10 4
PRP6 Pre-mRNA-processing factor 6 O94906 0 3 6 4 2 8 9 16 4 24 21 0 96 84
PRP8 Pre-mRNA-processing-splicing factor
8
Q6P2Q9 0 45 53 87 8 54 74 93 13 126 73 0 249 198
PRP19 Pre-mRNA-processing factor 19 Q9UMS4 0 26 34 30 0 9 26 43 0 16 11 3 46 36
PRP40A Pre-mRNA-processing factor 40
homolog A
O75400 0 9 19 13 0 10 10 23 0 17 10 0 46 38
RALY RNA-binding protein Raly Q9UKM9 7 26 47 49 8 52 46 61 22 99 30 10 40 38
SF3A1 Splicing factor 3A subunit 1 Q15459 0 7 6 20 0 10 16 18 0 5 4 0 27 30
SF3A3 Splicing factor 3A subunit 3 Q12874 0 0 5 5 0 6 12 20 0 4 4 0 11 2
SF3B1 Splicing factor 3B subunit 1 O75533 0 24 35 50 0 23 25 40 9 39 14 0 46 30
SF3B2 Splicing factor 3B subunit 2 Q13435 0 16 23 10 0 13 18 20 0 3 0 5 20 20
SF3B3 Splicing factor 3B subunit 3 Q15393 0 29 23 31 2 35 33 41 7 60 19 21 124 105
SF3B14 Pre-mRNA branch site protein p14 Q9Y3B4 0 2 4 10 0 0 5 11 2 7 0 0 8 6
SNRPA1 U2 small nuclear ribonucleoprotein
A'
P09661 0 7 9 10 0 10 7 14 3 4 8 4 13 10
SNRPB Small nuclear ribonucleoprotein-
associated proteins B and B'
P14678 0 18 2 18 23 36 19 47 2 24 4 4 36 30
SR140 U2 snRNP-associated SURP motif-
containing protein
O15042 0 9 13 15 0 6 12 16 0 14 0 0 9 3
SRSF1 Serine/arginine-rich splicing factor 1 Q07955 0 14 8 18 10 41 28 55 15 53 27 14 65 47
SRSF2 Serine/arginine-rich splicing factor 2 Q01130 0 3 7 20 5 15 22 41 0 11 6 2 15 16
SRSF6 Serine/arginine-rich splicing factor 6 Q13247 4 8 12 22 9 34 29 40 28 73 45 13 62 62
SRSF7 Serine/arginine-rich splicing factor 7 Q16629 0 8 14 15 4 13 15 40 12 69 22 14 42 33
SRSF9 Serine/arginine-rich splicing factor 9 Q13242 0 9 8 20 4 27 9 6 26 19
SRSF10 Serine/arginine-rich splicing factor 10 O75494 0 0 2 2 0 5 0 0 6 5
TRA2A Transformer-2 protein homolog alpha Q13595 0 14 4 4 22 21
TRA2B Transformer-2 protein homolog beta P62995 0 4 2 16 3 18 17 22 13 59 18 9 50 45
U2AF1 Splicing factor U2AF 35 kDa subunit Q01081 0 14 5 19 0 19 14 26 0 0 2 0 6 7
U2AF2 Splicing factor U2AF 65 P26368 0 0 5 11 0 0 7 13
U520 U5 small nuclear ribonucleoprotein
200 kDa helicase
O75643 0 47 54 96 7 38 45 57 15 93 55 8 149 121
U5S1 116 kDa U5 small nuclear
ribonucleoprotein component
Q15029 0 28 10 26 0 12 18 25 3 46 17 0 77 58
Other RNA processing factors
ADAR Double-stranded RNA-specific
adenosine deaminase (DSRAD)
P55265 0 2 9 12 0 2 9 12 0 56 6 0 21 10
SRRT Serrate RNA effector molecule
homolog
Q9BXP5 0 14 16 23 0 12 21 33 5 30 16 0 48 43
IMDH2 Inosine-5'-monophosphate
dehydrogenase 2
P12268 0 14 0 0 13 0
(Continued)
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compared to iPOND at 8 hpi (184 compared to 96). The types of proteins identified by ani-
POND are summarized in Fig 4C and individual proteins are listed in Tables 1–6 and Table A
in S1 Text. Proteins that copurified with viral genomes by aniPOND at 8 hpi share the same
functional categories as proteins that were purified by iPOND. In fact, pie charts that summa-
rize the findings from these two experiments show very similar trends (compare Figs 4C to 3C
8hpi).
Proteins that copurified with UL2/UL50 mutant genomes by iPOND and aniPOND at 8 hpi
were compared (Fig 4D). Fifty-three proteins were identified by both methods, 131 by only ani-
POND, and 43 by only iPOND. Differences in proteins identified by each method likely reflect
differences in the nature of DNA-protein interactions. For example, the viral helicase/primase
complex was identified by iPOND but not aniPOND (Table 2). Crosslinking during iPOND
could capture transient DNA-protein interactions or interactions that are lost during purifica-
tion, which may be the case for ATPases such as the helicase/primase complex. On the other
hand, the mediator of RNA polymerase II complex, as well as components of general transcrip-
tion factor TFIID and TFIIH were identified by aniPOND but not iPOND (Table 3). Members
of these complexes may not be in direct contact with the viral genome or may bind in an orien-
tation that is not conducive to crosslinking. We have shown previously that the mediator com-
plex, TFIID, and TFIIH copurify with ICP4 from virus-infected cells [34,35]. Here we also
confirmed that ICP4 coprecipitates with mediator and TFIID from virus infected resting
MRC-5 cells, along with a subset of transcription and chromatin remodeling factors that
copurify with viral DNA (Table B in S1 Text). Therefore, ICP4 may provide a means to target
these complexes to viral DNA.
Comparison of proteins identified by aniPOND of mutant genomes and wild type genomes
(Tables 1–6, Mutant vs. KOS) reveal similar trends and in almost all cases the same proteins
were found to be associated with both genomes. In fact, the most obvious difference is that
viral peptides for UL2 and UL50 gene products were not enriched on UL2/UL50 mutant ge-
nomes but were enriched on wild type genomes (Table 1). This provides validation for these
mutants not expressing UL2 and UL50 gene products and supports the use of mutant genomes
for the purification and identification of virus-associated proteins.
To provide support for the specificity of iPOND and aniPOND methods for the purification
of bona fide viral genome associated proteins, we searched the Contaminant Repository for Af-
finity Purification (CRAPome) [36] for cellular proteins identified by these methods (Fig F in
S1 Text). This web-based database includes 411 datasets of common contaminants present in
Table 6. (Continued)
RNA Processing Factors iPOND (Mutant) aniPOND (8hpi)
Experiment 1 Experiment 2 Experiment 1 Experiment 2
TREX complex Ctrl 6hpi 8hpi 12hpi Ctrl 6hpi 8hpi 12hpi Ctrl Mutant KOS Ctrl Mutant KOS
CPSF1 Cleavage and polyadenylation
specificity factor subunit 1
Q10570 0 14 4 0 27 7
PABP1 Polyadenylate-binding protein 1 P11940 13 15 37 47 9 33 30 64 26 147 46 2 123 49
PABP4 Polyadenylate-binding protein 4 Q13310 0 0 3 4 0 5 10 18 0 44 8 0 30 0
NCBP1 Nuclear cap binding protein 1 Q09161 0 2 2 9 0 0 2 5 0 7 0 0 8 9
ILF3 Interleukin enhancer-binding factor 3 Q12906 4 33 26 48 48 106 92 134 21 111 52 24 133 90
Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values
indicate spectral counts determined by mass spectrometry.
doi:10.1371/journal.ppat.1004939.t006
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negative controls for protein purification. Most proteins that were identified in this study were
found in less than 20% of the negative control datasets, consistent with specific enrichment of
viral genome associated proteins by these methods.
Taken together, aniPOND is an alternative method for the purification of virus-associated
proteins and may be more useful in situations were few genomes are present (for example be-
fore DNA replication) or when genomes are not efficiently labeled with nucleoside analogs (for
example wild type KOS). Furthermore, the combination of both methods reveals a comprehen-
sive look at proteins associated with viral genomes.
Fig 4. aniPOND detects viral and cellular proteins associated with replicated viral genomes. (A) ICP4 was detected in protein eluates from aniPOND
experiments carried out on wild type KOS or UL2/UL50 mutant virus by western blotting. AniPOND was carried out on virus grown in the presence (+) or
absence (-) of 2.5 μMEdU at 4–8 hpi and/or 33 μM acycloguanosine (ACG) throughout infection. (B) DNA eluted from streptavidin-coated beads during
aniPOND experiments in (A) is viral. The amount of viral DNA present in cell lysates (input) and eluted from beads (bound) during aniPOND experiments was
measured by qPCR of the viral TK gene. The ratio of viral DNA (vDNA) to total DNA was calculated and is presented in log %vDNA. Values for virus grown in
the presence of ACG are too small to be displayed on this graph. These experiments were carried out with the UL2/UL50mutant virus. (C) Pie charts
summarize proteins that were identified by mass spectrometry of protein eluates from aniPOND carried out on the UL2/UL50 mutant grown in the presence of
EdU at 4–8 hpi. Pie charts represent proteins that were identified with high confidence in independent duplicate experiments. Values indicate the number of
proteins identified for each functional category. (D) Venn diagrams depict the overlap of proteins identified by iPOND and aniPOND carried out on the UL2/
UL50 mutant 8 hpi.
doi:10.1371/journal.ppat.1004939.g004
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Cellular factors relocalize to viral replication compartments during HSV
infection
To better visualize the reorganization of host nuclear factors to viral replication compartments
during lytic infection with HSV, we used immunofluorescence to compare the distribution of
cellular factors in the nucleus of mock-infected cells to cells infected with KOS for 8 hours
(Fig 5). Ten cellular proteins that were identified by iPOND and/or aniPOND, including repli-
cation proteins PCNA and TOP2, transcription factors TFII-I, Spt5, Spt6, and XPD, chromatin
remodeling factors SSRP1, HMGB1, and HDAC2, as well as the repair protein Ku70 were test-
ed for colocalization with viral DNA. In all cases, the cellular proteins relocalized to viral repli-
cation compartments. Interestingly, these cellular factors were relocated from multiple
locations within the nucleus. Taken together, it is clear that HSV infection induces gross reor-
ganization of the host nucleus and compartmentalization of cellular factors that likely partici-
pate in multiple aspects of the virus life cycle.
HSV genomes are deficient for histones during lytic infection
Micrococcal nuclease digestion assays indicate that packaged genomes are not associated with
nucleosomes, only a small portion of incoming unreplicated genomes are associated with nu-
cleosomes, and newly replicated genomes are not associated with nucleosomes [37–39]. How-
ever, ChIP mapping data indicate that histones are bound to many HSV promoters and genes,
and often have marks of active chromatin [40,41]. The working model is that histones are pres-
ent on viral genomes during early lytic infection, the distribution and density of histones on
lytic genomes is significantly less than the host genome, and histones likely play a role in the
regulation of viral gene expression. In contrast, latent genomes are associated with ordered
chromatin similar to host cell DNA [42].
Many components of chromatin remodeling complexes were identified on replicated viral
genomes by iPOND and aniPOND (Table 4). These include members of the FACT, INO80,
NURD, and SWI/SNF chromatin remodeling complexes, as well as DNA and chromatin modi-
fying enzymes. However, histones were not enriched on purified replicated genomes, with the
exceptions of a few histone H1 variants, which were also abundant in negative controls
(Table 4 and Fig F in S1 Text). Perhaps chromatin remodeling factors associate with viral DNA
to facilitate the removal of histones or to keep histones from binding to newly
replicated genomes.
To provide support for the absence of histones on replicating genomes, colocalization of
viral genomes with histones was assayed by fluorescence microscopy. EdU-labeled viral repli-
cation compartments were tagged with Alexa Fluor 488 and either histone H1 (all subtypes; Fig
6A) or H3 (6B) was labeled with specific antibodies for immunofluorescence. Less dense locali-
zation of both histones was observed with viral DNA relative to cellular DNA. This localization
pattern greatly contrasts the pattern observed for proteins that were identified to associate with
viral genomes (Fig 5). These data support iPOND and aniPOND results and confirm that his-
tones are not enriched on viral genomes during DNA replication.
To assay for the colocalizaiton of viral genomes with histones during early lytic infection,
fluorescence imaging of prelabeled incoming viral genomes was carried out at 2 hpi (Fig 7).
Histones H1 and H3 did not colocalize with incoming viral genomes, at least within limits of
detection by immunofluorescence. This is in stark contrast to the pattern of ICP4 colocaliza-
tion with incoming genomes. In conclusion, iPOND, aniPOND, and imaging data provide sup-
port for a deficiency of histones on viral genomes throughout lytic infection
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Discussion
In this study, we adapted procedures that have been used to label and purify cellular replication
forks to label and purify replicating HSV-1 genomes. We have engineered mutant HSV strains
that increase EdU incorporation into replicating viral genomes allowing for more sensitive im-
aging and purification of viral DNA. We are the first to label HSV DNA to track the fate of in-
coming viral genomes within an infected cell, demonstrating its colocalization with ICP4
expressed from those genomes. We have optimized the iPOND and aniPONDmethods to
study HSV genomes during different stages of the HSV life cycle by these methods. From these
studies we have compiled a comprehensive list of proteins that are selectively recruited to HSV
genomes during and after viral DNA replication. By imaging the relocalization of several of
these factors to viral replication compartments during infection, we have demonstrated the ex-
tent to which host nuclei are largely reorganized during viral infection. Finally, we show that
viral genomes isolated by iPOND and aniPOND have a relatively low abundance of histones,
which is consistent with the lack of colocalization of genomes with histones H1 and H3. Data
presented in this paper provide a comprehensive view of viral and cellular proteins that associ-
ate with replicating HSV genomes during productive infection and provide insight into how
HSV manipulates host cell nuclear machineries for the expression, replication, and mainte-
nance of its genome.
In this study, we identified>200 viral and cellular proteins that are associated with HSV ge-
nomes after the onset of DNA replication. The overall most abundant proteins found on the
genome include the viral transcription factor ICP4 (Table 3), and the viral replication proteins
UL29 (ICP8, major DNA binding protein), UL30 (viral DNA polymerase), and UL42 (proces-
sivity factor) (Table 2). The identified cellular proteins function in host cell nuclear processes
including DNA replication, repair, chromatin remodeling, transcription, RNA processing, and
nuclear transport (Figs 3C and 4C).
Viral DNA replication
In addition to UL29, UL30, and UL42, four other viral replication factors, UL9 (origin binding
protein) and UL5/UL8/UL52 (helicase primase complex) were enriched on viral genomes. In
contrast to iPOND studies of cellular replication forks [23,26,28], most cellular DNA replica-
tion proteins did not copurify with viral genomes. However, the cellular processivity factor
PCNA and topoisomerases TOP1, TOP2a, and TOP2b were reproducibly enriched on replicat-
ing viral genomes. iPOND data indicate that the levels of PCNA on viral genomes is higher at 6
hpi than at 8 and 12 hpi, suggesting that PCNA may play a role in early phases of viral DNA
replication. Topoisomerases are important for relaxing supercoiled DNA as a consequence of
helicase unwinding during replication and transcription [43], and likely carryout this same
function on viral DNA. PCNA (Fig 5)[44] and Top2 (Fig 5) redistribute to viral replication
compartments during viral DNA replication, however a direct role in HSV replication has yet
to be demonstrated. Currently, there is not a good system to study origin-primed viral DNA
replication in vitro [20]. It is possible that cellular PCNA or topoisomerases are the missing
players in these reconstitution assays.
Fig 5. Proteins identified to interact with HSV-1 genomes by iPOND and aniPOND relocalize to viral replication compartments during lytic
infection. Vero cells infected with wild type KOS were grown in the presence of 10 μMEdU at 4–8 hpi. Cellular DNA was visualized by Hoechst staining, viral
replication compartments (vDNA) by click chemistry with EdU, and cellular proteins by immunofluorescence at 8 hpi (panels KOS, 8 hpi). Mock infected cells
(panels Mock) display the normal distribution of cellular proteins in the nucleus in the absence of HSV infection. For KOS infected cells, the first merged panel
displays colocalization of viral DNA with cellular proteins. The second merged panel shows the localization of viral DNA and cellular proteins with respect to
cellular DNA.
doi:10.1371/journal.ppat.1004939.g005
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The DNA damage response, repair, and recombination
We also identified several components involved in double strand break (DSB) recognition and
repair associated with replicating viral genomes in our assays. These include Ku70 and Ku80,
the Mre11/Rad50/Nbs1 (MRN) complex, ataxia telangiectasia mutated (ATM), and the catalyt-
ic subunit of DNA dependent protein kinase (DNA-PKcs) (Table 5). Ku70 (Fig 5) and Ku80
[45] colocalize with viral replication compartments. However, Ku70 expression is inhibitory
for viral DNA replication [45]. Perhaps, these proteins participate in a cellular antiviral re-
sponse in attempt to control virus multiplication.
The MRN complex, ATM, and activation of the DNA damage response are beneficial for
HSV genome replication [46–48]. The MRN complex and ATM are recruited to viral replica-
tion compartments and ATM is activated through autophosphorylation to trigger the DNA
damage response and cell cycle arrest through multiple pathways. In this way, the cell recog-
nizes the viral genome as DNA damage. However, downstream binding of cellular proteins
that mediate repair through nonhomologous end joining (NHEJ) and homologous recombina-
tion (HR) pathways are inhibited by the actions of the viral E3 ubiquitin ligase, ICP0 [49–51].
ICP0 targets downstream factors in these double strand break repair pathways for degradation,
including DNA-PKcs, RNF8, and RNF168. Consistent with these data, we did not identify
RNF8 or RNF168 to be recruited to viral DNA in our assays. Purification of DNA-PKcs is not
inconsistent with these observations because only 50% of DNA-PKcs is degraded by ICP0 and
this is likely cell type specific [45]. These data support a scenario whereby viral genomes trigger
the DNA damage response and cell cycle arrest to create an environment that is conducive to
viral DNA replication. ICP0 may inhibit the actions of cellular HR and NHEJ pathways for the
repair of virus ends, as well as nicks and gaps that occur during viral DNA replication. It is pos-
sible that HSV-1 instead uses its own machinery for recombination and repair during DNA
replication, mediated by the actions of ICP8 and UL12 (alkaline nuclease) [52,53]. In fact,
UL12 has been shown to interact with components of the MRN complex and may therefore act
with the MRN complex to carryout virus specific recombination [54].
The structural maintenance of chromosomes (SMC) family of ATPases function to stabilize
and organize chromosomes during mitosis [55]. Of these complex members, SMC1 and
SMC3, which make up the core of the cohesion complex, reproducibly copurify with replicat-
ing viral genomes. The cohesion complex is essential for sister chromatid cohesion during mi-
tosis, but also plays a role in transcription and DNA repair by recombination [56]. Cohesin
complex proteins SMC3 and Rad21 have previously been shown to associate with Epstein-Barr
virus genomes [57,58]. Perhaps these proteins are involved in HSV gene expression or recom-
bination during DNA replication. Mismatch repair [59] and base excision repair [60] pathways
also function in maintaining HSV genomes, and specific factors involved in both of these types
of repair were found to be associated with viral genomes in this study (Table 5).
RNA processing
RNA processing factors involved in all steps in pre-mRNA processing including capping, splic-
ing, polyadenylation, and export were abundant on viral genomes (Table 6). Interestingly,
ICP27, an essential viral immediate early gene product that regulates all steps in viral RNA pro-
cessing [61] was not readily detectable on genomes. However, the TREX complex was found in
our studies, which has been shown to interact with ICP27 [62,63] and to be involved in the ex-
port of KSHV intronless mRNAs [64]. RNA helicases, which are involved in all aspects of RNA
metabolism, as well as components of the nuclear transport machinery were also found associ-
ated with viral genomes. The abundant isolation of all of these RNA processing factors is most
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likely consistent with the high level accumulation of viral mRNA late after infection and the
fact that transcription and RNA processing are coupled [65–67].
Chromatin remodeling and transcription
Multiple components of several chromatin remodeling complexes were enriched on viral ge-
nomes including the FACT, INO80, NURD, and SWI/SNF complexes (Table 4). This is consis-
tent with proteomic analysis of proteins bound to ICP4 extracted from virus infected cells, in
which components of INO80, NURD, and SWI/SNF complexes were identified [34]. One of the
FACT complex members, SPT16, was shown to copurify with ICP8 in the absence of DNAse
treatment [45] and here we demonstrated the redistribution of the other FACT complex member
SSRP1 to viral replication compartments (Fig 5). As discussed above, histones were not enriched
on viral genomes, raising the possibility that these complexes maintain a nucleosome or histone
free state, greatly facilitating processes such as replication and transcription on the genome. The
FACT complex has been shown to disrupt nucleosome structure and allow DNA and RNA poly-
merases to access the DNA [68], the INO80 complex mediates nucleosome sliding [69], the
NURD complex has both histone deacetylase and nucleosome remodeling functions [70], and
high mobility group (HMG) proteins, which are also found on viral genomes, have been shown
to increase accessibility of chromatin-bound DNA [71]. Furthermore, the INO80 and FACT
complexes have also been implicated in cellular DNA damage repair by homologous recombina-
tion [72,73], and may therefore also play roles in mechanisms of viral DNA recombination.
HMGB1 was previously shown to function as a coactivator for ICP4 mediated transcription in
vitro [74], and may therefore function to mediate promoter specific activation of viral genes.
RNA polymerase II (polII) was abundant on isolated viral genomes (Table 3), with RPB1
and RPB2 being the most enriched subunits, most likely because they make direct contact with
DNA during transcription [75]. The transcription elongation factors Spt5, Spt6 [76], and
Trim28 [77] were also found associated with viral genomes and Spt5 and Spt6 were shown to
relocalize to viral replication compartments (Fig 5). These are therefore likely candidates to
regulate elongation during HSV transcription. TFII-I binds to initiator (inr) elements in cellu-
lar promoters [78] and therefore may play a role in the expression of late viral genes.
The viral transcriptional regulators VP16, ICP4, and ICP22 were found on viral genomes by
both iPOND and aniPOND. ICP22 was previously found to associate with ICP4 and RNA polII
in transcription complexes [79] and to mediate phosphorylation of polII [80]. VP16 is a tegu-
ment protein that activates transcription of immediate early viral genes [11]. ICP4 regulates ex-
pression from early and late HSV promoters and repression of immediate early promoters. It
interacts with TFIID, TFIIH, and a specific form of the mediator complex that lacks Med26 and
contains the kinase domain [34,35]. Here we show that viral genomes copurified with subunits
of TFIID, TFIIH, and the same form of the mediator complex that copurified with ICP4 from
Vero [34] and resting MRC-5 cells (Table B in S1 Text). This form of mediator possesses the ki-
nase domain, but lacks med26, and thus may be involved in repression, possibly of immediate
early promoters late after infection. The viral genes transcribed late after infection all possess rel-
atively simple TATA box-containing promoters, yet are abundantly transcribed. The accumu-
lated data support a model where ICP4 plays an integral role in recruiting most of the key polII
transcription factors, such as TFIID, required for abundant late transcription.
Fig 6. Histones H1 and H3 do not colocalize with replicated HSV genomes. (A) Infected Vero cells were maintained in the presence of EdU at 4–8 hpi.
Cellular DNA was visualized by Hoechst staining, viral replication compartments by click chemistry with EdU, and histone H1 by immunofluorescence.
Merged panels show the lack of colocalization of viral DNA with histone H1. Uninfected cells are shown as a control for normal histone distribution in the
nucleus. (B) Imaging was carried out as in (A) except that immunofluorescence was carried out with antibodies specific for histone H3.
doi:10.1371/journal.ppat.1004939.g006
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This study has provided a comprehensive view of the viral and cellular proteins associated
with replicating HSV genomes and provides new insight into cellular mechanisms that regulate
HSV infection. The presence of cellular proteins involved in a variety of nuclear processes is
consistent with the rapid and high level of accumulation of viral transcripts, replicated ge-
nomes, and progeny virions shortly after infection. This must be accompanied by the recombi-
nation and repair of replicating genomes. It is probable that the association and function of
these factors is facilitated by the relative dearth of cellular chromatin, which may be a function
of the recruitment of multiple chromatin remodeling complexes. In this model, ICP4 binding
to the genome, may have multiple roles in recruiting chromatin remodeling complexes and key
polII transcription complexes, although a direct role of ICP4 in chromatin organization has yet
to be demonstrated. What remains to be studied is to what extent this state is determined prior
to the onset of viral DNA replication.
Materials and Methods
Cells and viruses
Experiments were performed using MRC-5 (human embryonic lung) or Vero (African green
monkey kidney) cells obtained from and propagated as recommended by ATCC. The viruses
used in this study include the wild type HSV-1 strain, KOS, as well as UL2, UL50, and UL2/
UL50 mutant viruses. Mutants were generated in bacterial artificial chromosomes (BACs) con-
taining full-length, infectious KOS DNA [81] using two-step red-mediated recombination
[82,83]. To generate the UL2 null virus, the cassette GGCTAGTTAACTAGCC, which contains
a premature termination codon in all three reading frames, as well as an HpaI restriction site
for validation, was inserted after the codon for cysteine 75 of the UL2 open reading frame. For
the UL50 null virus, the codon for alanine 110 was replaced with this cassette. Mutant KOS--
BAC constructs were transfected using Lipofectamine 2000 Transfection Reagent (Life Tech-
nologies) and propagated in Vero cells. Viral DNA was isolated from individual plaques [84]
and screened for mutations by Southern blotting [85].
Preparation of prelabeled viral genomes
To generate prelabeled virus stocks, 1x108 Vero cells were infected with unlabeled KOS or
UL2/UL50 at an MOI of 10 PFU/cell at 37°C for 1 hour. After rinsing with tris-buffered saline
(TBS) to remove unadsorbed virus, media was replaced with Dulbecco’s Modified Eagle Medi-
um (DMEM) containing 5% fetal bovine serum (FBS). Four hpi, EdU (Sigma-Aldrich) was
added to the growth medium at the indicated concentration and incubated for an additional
34–36 hours. Monolayers were harvested, freeze-thawed three times at -80°C, sonicated, and
clarified by low-speed centrifugation. Viral titers were determined by plaque assay on Vero
cells.
Click chemistry and immunofluorescence
A total of 2x105 Vero cells were grown on glass coverslips in 12-well dishes. Infections were
carried out at an MOI of 10 in 100 μl TBS for 1 hour at room temperature. After infection, in-
oculum was removed and cells were rinsed with 1 ml TBS prior to addition of 1 ml DMEM
Fig 7. Histones H1 and H3 do not colocalize with incoming HSV genomes. Vero cells infected with KOS
virus (prelabeled with 10 μMEdU) were assayed for colocalization with histones H1 and H3 at 2 hpi. Nuclei
are shown with incoming viral genomes visualized by click chemistry with EdU, and histone H1, histone H3,
or ICP4 by immunofluorescence. Merged panels show the lack of colocalization of viral DNA with histones
and robust colocalization with ICP4.
doi:10.1371/journal.ppat.1004939.g007
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plus 5% FBS. Infections were carried out at 37°C for the indicated period of time, with or with-
out the addition of EdU to the growth medium. Cells were fixed with 3.7% formaldehyde for
15 min, washed two times with phosphate-buffered saline (PBS), permeabilized with 0.5% Tri-
ton-X 100 for 20 min, and blocked with 3% bovine serum albumin (BSA) for 30 min. EdU-la-
beled DNA was conjugated to Alexa Fluor 488 azide using the Click-iT EdU imaging kit
according to manufacturer’s protocol (Life Technologies). Cells were rinsed with PBS plus 3%
BSA, then PBS, labeled with Hoechst 33342 (1:2000 dilution) for 30 min, washed two times
with PBS, then incubated with primary antibody (mouse anti-ICP4: 58S, 1:500; mouse anti-his-
tone H1: ab4269 (Abcam), 1:1000; rabbit anti-histone H3: ab1791 (Abcam), 1:1000; mouse
anti-PCNA: sc-056 (Santa Cruz), 1:200; mouse anti-topoisomerase 2: NA14 (Calbiochem),
1:20; goat anti-TFII-I: sc-9943x (Santa Cruz), 1:200; rabbit anti-Spt5: A300-869A (Bethyl Labo-
ratories), 1:200; rabbit anti-Spt6: ab32820 (Abcam), 1:200; rabbit anti-TFIIH p89 (XPD): sc-
293 (Santa Cruz), 1:200; mouse anti-SSRP1: 10D1 (Biolegend), 1:200; rabbit anti-HMGB1:
ab18256 (Abcam), 1:1000; rabbit anti-HDAC2: sc-7899 (Santa Cruz), 1:200; rabbit anti-Ku70:
sc-9033 (Santa Cruz), 1:200) and Alexa Fluor 594-conjugated secondary antibodies (Santa
Cruz, 1:500) as described previously [34]. Images were obtained using an Olympus Fluoview
FV1000 confocal microscope.
iPOND
iPOND was carried out as described previously [25] with the following modifications. For each
condition, three 500 cm2 tissue culture dishes containing confluent monolayers of MRC-5 cells
(~7x107 cells/dish) were infected with UL2/UL50 double mutant virus at an MOI of 10 PFU/
cell for one hour at room temperature. After adsorption, the inoculum was removed and cells
were rinsed with TBS before addition of fresh DMEM plus 5% FBS. Cells were incubated at
37°C for the indicated period of time before addition of EdU at a final concentration of 2.5 μM.
After incubation for an additional 2–4 hours, cells were fixed with 1% (wt/vol) formaldehyde
in PBS for 15 min at room temperature, quenched with 125 mM glycine, and harvested by
scraping. Cell permeabilization, click chemistry, cell lysis, sonication, and streptavidin capture
were carried out as described except the samples were sonicated 6 times for 30 sec each at 7
watts using a Cole-Palmer ultrasonic processor with microtip. For each condition, samples
from three plates were combined, and proteins were eluted from streptavidin-coated beads by
boiling in 200 μl 2x SDS Laemmli sample buffer to reverse formaldehyde crosslinks.
aniPOND
aniPOND was carried out as described previously [33] with the following modifications. For
each condition, one 500 cm2 tissue culture dish containing a confluent monolayer of MRC-5
cells (~7x107 cells) was infected with wild type KOS or UL2/UL50 double mutant virus at an
MOI of 10 PFU/cell for one hour at room temperature. After adsorption, the inoculum was re-
moved and cells were rinsed with TBS before addition of fresh DMEM plus 5% FBS. Cells were
incubated at 37°C for four hours before the addition of EdU (Sigma-Aldrich) at a final concen-
tration of 2.5 μM, followed by an additional four-hour incubation. To detach the monolayer
and extract nuclei, 20 ml nuclear extraction buffer was added directly to each plate, incubated
at 4°C for 15 min, and harvested by scraping. Cell washes, click chemistry, cell lysis, sonication,
and streptavidin capture were carried out as described except for cell lysis cells were incubated
for 30 min total in lysis buffer and sonicated 8 times for 30 sec each at 7 watts. Proteins were
eluted from streptavidin-coated beads by boiling in 66 μl 2x SDS Laemmli sample buffer. For
aniPOND experiment 2, two plates of MRC-5 cells were used for analysis and for protein
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elution, streptavidin-coated beads from both samples were combined and proteins were eluted
in 66 μl 2x sample buffer to generate a 2x concentrated sample.
Western blotting
SDS polyacrylamide gel electrophoresis and western blotting were carried out as described pre-
viously [86]. Proteins were transferred to polyvinylidine fluoride membranes (Amersham) for
chemi-luminescent detection with ECL reagent (Amersham). For detection of ICP4, mem-
branes were probed with the 58S polyclonal mouse antibody (1:5000 dilution).
Mass spectrometry and data analysis
Mass spectrometry was carried out by MSBioworks. The entire sample was separated ~1.5cm
on a 10% Bis-Tris Novex mini-gel (Invitrogen) using the MES buffer system. The gel was
stained with coomassie and excised into ten equally sized segments. Gel segments were pro-
cessed as described and analyzed by nano liquid chromatography with tandem mass spectrom-
etry (LC/MS/MS) [87]. Data were searched using Mascot and Mascot DAT files were parsed
into the Scaffold software for validation, filtering, and to create a nonredundant list per sample.
Data were filtered at 1% protein and peptide level false discovery rates and requiring at least
two unique peptides per protein. Proteins were considered most significantly enriched by
iPOND or aniPOND based on the following criteria: 1) protein had at least 5 spectral counts
(SpC) in the experimental sample, 2) protein was not detected in the control or was enriched
over the control by at least four-fold based on dividing SpC values, and 3) was detected in du-
plicate experiments. Raw SpC data without normalization are presented in Tables 1–6 and
Table A in S1 Text.
DNA isolation and quantitative real-time PCR (qRT-PCR)
DNA was isolated from 1/20th volume cell lysates or 1/10th volume streptavidin-coated beads
during iPOND and aniPOND experiments. For isolation of DNA from cell lysates, an equal
volume of 2x SDS-bicarb solution (2% SDS, 0.2 M NaHCO3) was added to the sample and for
isolation of bead-bound DNA, beads were resuspended in 1x SDS-bicarb solution. Samples
were incubated at 65°C overnight, followed by extraction with phenol:chloroform:isoamyl alco-
hol (25:24:1) and chloroform:isoamyl alcohol (24:1). DNA was recovered using the MinElute
PCR Purification kit (Qiagen). DNA concentrations were measure using a Quibit Fluorometer
and the Qubit dsDNA HS Assay Kit (Life Technologies).
qRT-PCR was carried out as described previously [88]. The HSV-1 TK gene was amplified to
estimate the amount of viral DNA in each sample. Primers used for amplification of the HSV
TK gene were TkdsF1 (5´-ACCCGCTTAACAGCGTCAACA-3´) and TkdsR1 (5´-CCAAAGA
GGTGCGGGAGTTT-3´). Standard curves were generated using purified KOS DNA.
Supporting Information
S1 Text. Includes Supporting Materials and Methods, Supplemental Figures A-F, and Sup-
plemental Tables A and B.
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